These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31413800)

  • 1. Evaluation of a Series of β-Secretase 1 Inhibitors Containing Novel Heteroaryl-Fused-Piperazine Amidine Warheads.
    Oehlrich D; Peschiulli A; Tresadern G; Van Gool M; Vega JA; De Lucas AI; Alonso de Diego SA; Prokopcova H; Austin N; Van Brandt S; Surkyn M; De Cleyn M; Vos A; Rombouts FJR; Macdonald G; Moechars D; Gijsen HJM; Trabanco AA
    ACS Med Chem Lett; 2019 Aug; 10(8):1159-1165. PubMed ID: 31413800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in the development of beta-secretase inhibitors for Alzheimer's disease.
    Albert JS
    Prog Med Chem; 2009; 48():133-61. PubMed ID: 21544959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Brain-Penetrant and Bioavailable Pyrazolopiperazine BACE1 Inhibitor Elicits Sustained Reduction of Amyloid β In Vivo.
    Peschiulli A; Oehlrich D; Van Gool M; Austin N; Van Brandt S; Surkyn M; De Cleyn M; Vos A; Tresadern G; Rombouts FJR; Macdonald GJ; Moechars D; Trabanco AA; Gijsen HJM
    ACS Med Chem Lett; 2022 Jan; 13(1):76-83. PubMed ID: 35059126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spirocyclic sulfamides as β-secretase 1 (BACE-1) inhibitors for the treatment of Alzheimer's disease: utilization of structure based drug design, WaterMap, and CNS penetration studies to identify centrally efficacious inhibitors.
    Brodney MA; Barreiro G; Ogilvie K; Hajos-Korcsok E; Murray J; Vajdos F; Ambroise C; Christoffersen C; Fisher K; Lanyon L; Liu J; Nolan CE; Withka JM; Borzilleri KA; Efremov I; Oborski CE; Varghese A; O'Neill BT
    J Med Chem; 2012 Nov; 55(21):9224-39. PubMed ID: 22984865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiwell fluorometric and colorimetric microassays for the evaluation of beta-secretase (BACE-1) inhibitors.
    Mancini F; Naldi M; Cavrini V; Andrisano V
    Anal Bioanal Chem; 2007 Jul; 388(5-6):1175-83. PubMed ID: 17541560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics.
    Roberds SL; Anderson J; Basi G; Bienkowski MJ; Branstetter DG; Chen KS; Freedman SB; Frigon NL; Games D; Hu K; Johnson-Wood K; Kappenman KE; Kawabe TT; Kola I; Kuehn R; Lee M; Liu W; Motter R; Nichols NF; Power M; Robertson DW; Schenk D; Schoor M; Shopp GM; Shuck ME; Sinha S; Svensson KA; Tatsuno G; Tintrup H; Wijsman J; Wright S; McConlogue L
    Hum Mol Genet; 2001 Jun; 10(12):1317-24. PubMed ID: 11406613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inkjet printing-based β-secretase fluorescence resonance energy transfer (FRET) assay for screening of potential β-secretase inhibitors of Alzheimer's disease.
    Lee J; Samson AAS; Song JM
    Anal Chim Acta; 2018 Aug; 1022():89-95. PubMed ID: 29729742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of donepezil analogues as dual AChE and BACE-1 inhibitors.
    Gabr MT; Abdel-Raziq MS
    Bioorg Chem; 2018 Oct; 80():245-252. PubMed ID: 29966870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic insights into mode of action of potent natural antagonists of BACE-1 for checking Alzheimer's plaque pathology.
    Dhanjal JK; Goyal S; Sharma S; Hamid R; Grover A
    Biochem Biophys Res Commun; 2014 Jan; 443(3):1054-9. PubMed ID: 24365147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of novel 3,5-bis-N-(aryl/heteroaryl) carbamoyl-4-aryl-1,4-dihydropyridines as small molecule BACE-1 inhibitors.
    Razzaghi-Asl N; Firuzi O; Hemmateenejad B; Javidnia K; Edraki N; Miri R
    Bioorg Med Chem; 2013 Nov; 21(22):6893-909. PubMed ID: 24113238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of Alzheimer's BACE-1 with 3,5-bis-N-(aryl/heteroaryl) carbamoyl-4-aryl-1,4-dihydropyridine structure.
    Miri R; Firuzi O; Razzaghi-Asl N; Javidnia K; Edraki N
    Arch Pharm Res; 2015 Apr; 38(4):456-69. PubMed ID: 24771353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diastereoselective synthesis of fused cyclopropyl-3-amino-2,4-oxazine β-amyloid cleaving enzyme (BACE) inhibitors and their biological evaluation.
    Low JD; Bartberger MD; Cheng Y; Whittington D; Xue Q; Wood S; Allen JR; Minatti AE
    Bioorg Med Chem Lett; 2018 Apr; 28(6):1111-1115. PubMed ID: 29426770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico discovery of beta-secretase inhibitors.
    Huang D; Lüthi U; Kolb P; Cecchini M; Barberis A; Caflisch A
    J Am Chem Soc; 2006 Apr; 128(16):5436-43. PubMed ID: 16620115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of cyclic acylguanidines as highly potent and selective beta-site amyloid cleaving enzyme (BACE) inhibitors: Part I--inhibitor design and validation.
    Zhu Z; Sun ZY; Ye Y; Voigt J; Strickland C; Smith EM; Cumming J; Wang L; Wong J; Wang YS; Wyss DF; Chen X; Kuvelkar R; Kennedy ME; Favreau L; Parker E; McKittrick BA; Stamford A; Czarniecki M; Greenlee W; Hunter JC
    J Med Chem; 2010 Feb; 53(3):951-65. PubMed ID: 20043696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of synthesis, biological assay and QSAR studies of β-secretase inhibitors.
    Niño H; García-Pintos I; Rodríguez-Borges JE; Escobar-Cubiella M; García-Mera X; Prado-Prado F
    Curr Comput Aided Drug Des; 2011 Dec; 7(4):263-75. PubMed ID: 22050682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of fragment-based lead generation to the discovery of novel, cyclic amidine beta-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency.
    Edwards PD; Albert JS; Sylvester M; Aharony D; Andisik D; Callaghan O; Campbell JB; Carr RA; Chessari G; Congreve M; Frederickson M; Folmer RH; Geschwindner S; Koether G; Kolmodin K; Krumrine J; Mauger RC; Murray CW; Olsson LL; Patel S; Spear N; Tian G
    J Med Chem; 2007 Nov; 50(24):5912-25. PubMed ID: 17985862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacophore based 3D-QSAR modeling, virtual screening and docking for identification of potential inhibitors of β-secretase.
    Palakurti R; Vadrevu R
    Comput Biol Chem; 2017 Jun; 68():107-117. PubMed ID: 28288354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural bioinformatics-based identification of EGFR inhibitor gefitinib as a putative lead compound for BACE.
    Niu M; Hu J; Wu S; Xiaoe Z; Xu H; Zhang Y; Zhang J; Yang Y
    Chem Biol Drug Des; 2014 Jan; 83(1):81-8. PubMed ID: 24516878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE.
    Vassar R; Bennett BD; Babu-Khan S; Kahn S; Mendiaz EA; Denis P; Teplow DB; Ross S; Amarante P; Loeloff R; Luo Y; Fisher S; Fuller J; Edenson S; Lile J; Jarosinski MA; Biere AL; Curran E; Burgess T; Louis JC; Collins F; Treanor J; Rogers G; Citron M
    Science; 1999 Oct; 286(5440):735-41. PubMed ID: 10531052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naphthyl and coumarinyl biarylpiperazine derivatives as highly potent human beta-secretase inhibitors. Design, synthesis, and enzymatic BACE-1 and cell assays.
    Garino C; Tomita T; Pietrancosta N; Laras Y; Rosas R; Herbette G; Maigret B; Quéléver G; Iwatsubo T; Kraus JL
    J Med Chem; 2006 Jul; 49(14):4275-85. PubMed ID: 16821787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.